Search Results - "Kartsios, Charalambos"

Refine Results
  1. 1

    The Role of Hepcidin in Iron Homeostasis and Anemia in Hemodialysis Patients by Eleftheriadis, Theodoros, Liakopoulos, Vassilios, Antoniadi, Georgia, Kartsios, Charalambos, Stefanidis, Ioannis

    Published in Seminars in dialysis (01-01-2009)
    “…Anemia is a common complication in hemodialysis (HD) patients. Despite the great success of recombinant human erythropoietin in clinical practice, resistance…”
    Get full text
    Journal Article
  2. 2

    Increased Plasma Angiogenin Level is Associated and May Contribute to Decreased T-Cell Zeta-Chain Expression in Hemodialysis Patients by Eleftheriadis, Theodoros, Kartsios, Charalambos, Pissas, Georgios, Liakopoulos, Vassilios, Antoniadi, Georgia, Galaktidou, Grammati, Stefanidis, Ioannis

    Published in Therapeutic apheresis and dialysis (01-02-2013)
    “…Hemodialysis (HD) patients are characterized by impaired T‐cell function at least in part because of T‐cell zeta‐chain downregulation due to inflammation…”
    Get full text
    Journal Article
  3. 3

    Effect of One-year Oral α-Tocopherol Administration on the Antioxidant Defense System in Hemodialysis Patients by Antoniadi, Georgia, Eleftheriadis, Theodoros, Liakopoulos, Vassilios, Kakasi, Eleni, Kartsios, Charalambos, Passadakis, Ploumis, Vargemezis, Vassilis

    Published in Therapeutic apheresis and dialysis (01-06-2008)
    “…:  Oxidative stress is increased in hemodialysis (HD) patients and contributes to the increased morbidity and mortality in this population. Vitamin E is an…”
    Get full text
    Journal Article
  4. 4

    Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients by Eleftheriadis, Theodoros, Kartsios, Charalambos, Yiannaki, Efi, Kazila, Polizo, Antoniadi, Georgia, Liakopoulos, Vassilios, Markala, Dimitra

    Published in Blood purification (01-01-2008)
    “…Natural killer (NK) cell activity is decreased in hemodialysis (HD) patients. Zeta-chain phosphorylation is an early event that follows the triggering of some…”
    Get more information
    Journal Article
  5. 5

    Basic Science and Dialysis: Disturbances of Acquired Immunity in Hemodialysis Patients by Eleftheriadis, Theodoros, Antoniadi, Georgia, Liakopoulos, Vassilios, Kartsios, Charalambos, Stefanidis, Ioannis

    Published in Seminars in dialysis (01-09-2007)
    “…Acquired immunity disturbances in hemodialysis (HD) patients are many and diverse. They are caused by uremia per se, the HD procedure, chronic renal failure…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Isolated Splenic Mycobacterial Disease: A Cause of Persistent Fever in a Hairy Cell Leukemia Patient by Papadopoulos, Vassilios, Kartsios, Charalambos, Spyrou, Anastassia, Loukidis, Kostas, Miyakis, Spyridon, Pervana, Stavroula, Makridis, Charalambos, Kioumi, Anna, Korantzis, Ioannis

    Published in Case reports in gastroenterology (11-09-2010)
    “…We describe a 69-year-old male patient who was referred for the investigation of long-lasting fever, anemia and neutropenia. Hairy cell leukemia was diagnosed…”
    Get full text
    Journal Article
  8. 8

    Disturbances of acquired immunity in hemodialysis patients by Eleftheriadis, Theodoros, Antoniadi, Georgia, Liakopoulos, Vassilios, Kartsios, Charalambos, Stefanidis, Ioannis

    Published in Seminars in dialysis (01-09-2007)
    “…Acquired immunity disturbances in hemodialysis (HD) patients are many and diverse. They are caused by uremia per se, the HD procedure, chronic renal failure…”
    Get full text
    Journal Article
  9. 9

    Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-α and IL-8 production by human peripheral blood mononuclear cells by Eleftheriadis, Theodoros, Antoniadi, Georgia, Liakopoulos, Vassilios, Kartsios, Charalambos, Stefanidis, Ioannis, Galaktidou, Grammati

    Published in International urology and nephrology (01-03-2010)
    “…Introduction Vitamin D and its analogues proved to exert immunomodulatory effects. Paricalcitol is a vitamin D analogue that is safe. It has been used for…”
    Get full text
    Journal Article
  10. 10

    A case of a primary cutaneous plasmacytoma presenting in adolescence by Koletsa, Triantafyllia, Patsatsi, Aikaterini, Kostopoulos, Ioannis, Kartsios, Charalambos, Korantzis, Ioannis, Sotiriadis, Dimitrios

    Published in The American journal of dermatopathology (01-07-2012)
    “…Primary cutaneous plasmacytoma is defined as monoclonal proliferation of plasma cells that arises primarily in the skin without evidence of systemic disease…”
    Get full text
    Journal Article
  11. 11

    Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients by Eleftheriadis, Theodoros, Kartsios, Charalambos, Yiannaki, Efi, Kazila, Polizo, Antoniadi, Georgia, Liakopoulos, Vassilios, Markala, Dimitra

    Published in American journal of nephrology (01-01-2008)
    “…Clinical and experimental data indicate a deficient immune response in hemodialysis (HD) patients. zeta-Chain phosphorylation is an early and central event in…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: First reported case by Katodritou, Eirini, Kartsios, Charalambos, Gastari, Vassiliki, Verrou, Evgenia, Mihou, Dimitra, Banti, Anastasia, Lazaraki, Georgia, Lazaridou, Anna, Kaloutsi, Vassiliki, Zervas, Konstantinos

    Published in Leukemia research (01-02-2008)
    “…Abstract We report a case of a 68-year-old man presented with upper-gastrointestinal bleeding. Endoscopy showed a large ulcerated gastric mass. Histological…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients by ELEFTHERIADIS, THEODOROS, KARTSIOS, CHARALAMBOS, YIANNAKI, EFI, ANTONIADI, GEORGIA, KAZILA, POLIZO, PLIAKOS, KONSTANTINOS, LIAKOPOULOS, VASSILIOS, MARKALA, DIMITRA

    Published in Nephrology (Carlton, Vic.) (01-08-2009)
    “…SUMMARY Aim:  Clinical and experimental data indicate a deficient immune response in haemodialysis (HD) patients. Natural killer‐like (NKL) T cells express on…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Does hepcidin affect erythropoiesis in hemodialysis patients? by Eleftheriadis, Theodoros, Kartsios, Charalambos, Liakopoulos, Vassilios, Antoniadi, Georgia, Ditsa, Maria, Papadopoulos, Christos, Anifandis, Georgios, Skirta, Aliki, Markala, Dimitra, Stefanidis, Ioannis

    Published in Acta haematologica (01-01-2006)
    “…Prohepcidin is the precursor of hepcidin, a liver-derived peptide involved in iron metabolism by blocking its intestinal absorption and its release by the…”
    Get more information
    Journal Article
  18. 18

    The impact of chronic inflammation on bone turnover in hemodialysis patients by Eleftheriadis, Theodoros, Kartsios, Charalambos, Antoniadi, Georgia, Kazila, Polizo, Dimitriadou, Magdalini, Sotiriadou, Eleni, Koltsida, Maria, Golfinopoulos, Spiridon, Liakopoulos, Vassilios, Christopoulou-Apostolaki, Maria

    Published in Renal failure (01-01-2008)
    “…Renal osteodystrophy is very common in hemodialysis (HD) patients. HD is a chronic inflammatory state. Studies in other pathological entities have shown an…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-[alpha] and IL-8 production by human peripheral blood mononuclear cells by Eleftheriadis, Theodoros, Antoniadi, Georgia, Liakopoulos, Vassilios, Kartsios, Charalambos, Stefanidis, Ioannis, Galaktidou, Grammati

    Published in International urology and nephrology (01-01-2010)
    “…Vitamin D and its analogues proved to exert immunomodulatory effects. Paricalcitol is a vitamin D analogue that is safe. It has been used for years in the…”
    Get full text
    Journal Article